Biocompatibles UK Limited

Hepatocellular Carcinoma

Clinical research is focused on hepatocellular carcinoma, with interest in treatment strategies that combine radiation therapy and immunotherapy for liver cancer.

  • TheraSphere
  • Durvalumab
  • Tremelimumab

The sponsor’s active research activity in this area reflects a therapeutic emphasis on oncology, particularly liver malignancies and immune-based cancer treatment approaches.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of TheraSphere, Durvalumab, and Tremelimumab for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    2 1 1 1
    France Italy Spain